Details for New Drug Application (NDA): 019879
✉ Email this page to a colleague
The generic ingredient in ORNIDYL is eflornithine hydrochloride. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the eflornithine hydrochloride profile page.
Summary for 019879
Tradename: | ORNIDYL |
Applicant: | Sanofi Aventis Us |
Ingredient: | eflornithine hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 019879
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 200MG/ML | ||||
Approval Date: | Nov 28, 1990 | TE: | RLD: | No |
Expired US Patents for NDA 019879
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sanofi Aventis Us | ORNIDYL | eflornithine hydrochloride | INJECTABLE;INJECTION | 019879-002 | Nov 28, 1990 | ⤷ Sign Up | ⤷ Sign Up |
Sanofi Aventis Us | ORNIDYL | eflornithine hydrochloride | INJECTABLE;INJECTION | 019879-002 | Nov 28, 1990 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription